Streaming Web-based Exercise At Home: A Pilot Study

Inclusion criteria

• Male previously diagnosed with prostate cancer or female previously diagnosed with breast cancer.
• For breast cancer, minimum of 3 months post-active treatment completion. Active treatment includes chemotherapy, biologic therapy, radiation therapy, surgery, and any combination. Long-term hormonal/biologic treatments are acceptable.
• For prostate cancer, minimum of 3 months post-active treatment completion. Active treatment includes chemotherapy, biologic therapy, radiation therapy, surgery, and any combination. Long-term hormonal/biologic treatments are acceptable, except for androgen receptor-targeted therapies (such as enzalutamide, apalutamide, darolutamide, or abiraterone). Patients currently on active surveillance are eligible even if they have not received prior anti-cancer treatment.
• Has access to tablet, laptop, or desktop computer with video capabilities connected to the internet with a screen at least 13 inches across.
• Physically able to complete modified Bruce submaximal treadmill test, leg strength test, grip strength test, and InBody per patient self-assessment.
• Physician clearance to participate in this study. Can be done through review of patients' medical records.
• Ability to read, write, and understand English.
• Has a chair at home to use for exercise that is not on wheels and has a solid back (not a reclining chair).
• Ambulatory without assistance.
• Has a clear 5 x 6-foot space at home in which to exercise.
• Age >18 years.
• Written informed consent obtained from subject and ability for subject to comply with the requirements of the study.

Exclusion criteria

• Active treatment planned within the next 6 months. Active treatment includes chemotherapy, biologic therapy, radiation therapy, surgery, and any combination. Long-term hormonal/biologic treatments are acceptable, except for AR-targeted therapies for prostate cancer.
• Known metastatic disease.
• Grade 3 or higher peripheral neuropathy.
• Major surgery within 3 months of baseline visit.
• Positive pregnancy test for women of child-bearing potential.
• Answers yes to any question on the Physical Activity Readiness Questionnaire unless study participation is cleared by a physician.
• Known allergy to Fitbit device.
• Currently meeting physical activity guidelines (score of >23 on Godin-Shephard Leisure-Time Physical Activity Questionnaire).